The Leerink downgrade is a contrarian call from a low-accuracy firm, but the convergence with insider selling and elevated short interest creates a cautionary setup. Traders should monitor the August 5 earnings report for confirmation; a miss could accelerate the downside implied by the $127 target.
Price Chart
Executive Summary
Leerink Partners double-downgraded Gilead Sciences from Outperform to Market Perform on July 21, slashing its price target to $127 from $146, implying 4.7% downside from the current $133.21. The downgrade is a contrarian call against a heavily bullish consensus — 81% of analysts rate GILD Buy/Strong Buy, with a mean target of $158.30 (19% upside). Leerink's accuracy is below average at 49% on 257 calls, and its average return of 4.3% trails top-tier firms like RBC Capital (93% accuracy, 14.9% return). Recent insider selling by the CEO and other executives in July, totaling ~$3M, aligns with the bearish analyst action. However, institutional buying remains strong, with MASSACHUSETTS FINANCIAL SERVICES adding 48.7% to its position. EPS revisions for the current year (+1y) have been slightly positive over the past 30 days. The next earnings report is due August 5, adding a timing catalyst. Traders should view this downgrade as a cautionary signal from a low-accuracy firm, but the convergence with insider selling warrants attention.
Impact Score
Consensus & Targets
The consensus is heavily bullish: 10 Strong Buy, 20 Buy, 7 Hold, 0 Sell, 0 Strong Sell — 81% Buy/Strong Buy from 27 analysts. The downgrade is a contrarian move against the prevailing bullish consensus.
Mean target $158.30, median $160, high $180, low $120. Current price $133.21 implies 18.8% upside to the mean. Leerink's new $127 target is below the low end of consensus ($120) and 19.8% below the mean, making it one of the most bearish targets on the Street.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-21 | Leerink Partners | downgrade | Market Perform | $127.00 |
| 2026-07-08 | Morgan Stanley | maintain | Overweight | $166.00 |
| 2026-07-07 | RBC Capital | maintain | Sector Perform | $120.00 |
| 2026-07-07 | Truist Securities | maintain | Buy | $156.00 |
| 2026-07-06 | Cantor Fitzgerald | reiterate | Overweight | $155.00 |
| 2026-07-06 | HSBC | upgrade | Buy | $155.00 |
| 2026-06-16 | Cantor Fitzgerald | reiterate | Overweight | $155.00 |
| 2026-05-20 | Maxim Group | upgrade | Buy | $165.00 |
| 2026-05-08 | Truist Securities | reiterate | Buy | $157.00 |
| 2026-05-08 | RBC Capital | maintain | Sector Perform | $122.00 |
Over the past 30 days, analyst activity shows 1 upgrade (HSBC from Hold to Buy on July 6) and 1 downgrade (Leerink). EPS revisions for the current fiscal year (+1y) show 2 upward revisions vs 1 downward in the past 30 days, with the average estimate rising from $9.67 to $9.71. Near-term (+1q) estimates also saw 2 upward revisions with no downgrades.
Firm Track Record — Leerink Partners
Leerink Partners accuracy: 49% on 257 calls | avg return: 4.3%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Truist Securities | 100% | 4/4 | 9.7% | top tier |
| TD Cowen | 100% | 2/2 | 16.2% | top tier |
| Citigroup | 100% | 2/2 | 8.3% | top tier |
| UBS | 100% | 3/3 | 11.5% | top tier |
| Mizuho | 100% | 2/2 | 16.8% | top tier |
| RBC Capital | 93% | 13/14 | 14.9% | top tier |
| Needham | 89% | 8/9 | 12.2% | top tier |
| BMO Capital | 86% | 6/7 | 7.6% | top tier |
| JP Morgan | 86% | 6/7 | 6% | top tier |
| Cantor Fitzgerald | 86% | 6/7 | 17.9% | top tier |
Leerink Partners has a 49% accuracy rate on 257 scored calls with an average return of 4.3%. This is below the top-tier firms covering GILD: RBC Capital (93% on 14 calls, 14.9% return), Cantor Fitzgerald (86% on 7 calls, 17.9% return), and Mizuho (100% on 2 calls, 16.8% return). Leerink's track record is among the weakest of firms covering GILD.
Earnings Estimates
Next earnings: Aug 5, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| 0q | $-7.30 | $-7.93 — $-6.40 | $7.4B | ↑1 ↓0 |
| +1q | $2.23 | $1.41 — $2.57 | $7.8B | ↑2 ↓0 |
| 0y | $-0.77 | $-1.05 — $-0.26 | $30.5B | ↑1 ↓0 |
| +1y | $9.71 | $9.05 — $11.20 | $32.4B | ↑1 ↓0 |
Cross-Platform Signals
Insider selling is notable: CEO O'Day sold ~$1.9M on July 1, and two other executives sold ~$780K on July 15 — a bearish signal aligning with the downgrade. Congressional activity shows two small buys by Rep. Moskowitz (Democrat) in May. Institutional changes are mixed: MASSACHUSETTS FINANCIAL SERVICES added 48.7% ($910M position), while NORGES BANK exited completely. Short interest is elevated at 56.8% of off-exchange volume, indicating bearish positioning. The insider selling convergence with the downgrade adds weight to the bearish signal.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 2, 2026 4w ago | Insider Cluster | $149.61 $149.05 | ▼ −0.37% | ▼ −0.04% | $144.74 (−3.26%) |
Aug 27, 2026 5w ago | Insider Cluster | $145.68 $152.21 | ▲ +4.48% | ▲ +4.22% | $144.74 (−0.65%) |
Aug 21, 2026 5w ago | Insider Cluster | $146.74 $152.67 | ▲ +4.04% | ▲ +2.73% | $144.74 (−1.36%) |
Aug 18, 2026 6w ago | Insider Cluster | $147.60 $150.89 | ▲ +2.23% | ▲ +4.18% | $144.74 (−1.94%) |
Aug 18, 2026 6w ago | Court Ruling | $143.44 $147.68 | ▲ +2.96% | ▲ +4.27% | $144.74 (+0.91%) |
Aug 13, 2026 7w ago | Court Ruling | $138.14 $143.72 | ▲ +4.04% | ▲ +5.79% | $144.74 (+4.78%) |
Aug 6, 2026 8w ago | S-3ASR | $133.21 $151.00 | ▲ +13.35% | ▲ +13.75% | $144.74 (+8.66%) |
Jul 21, 2026 10w ago | ANALYST-DOWNGRADE | $130.28 $143.44 | ▼ −10.10% | ▼ −7.54% | $144.74 (−11.10%) |
Jul 16, 2026 11w ago | Insider Cluster | $134.28 $138.33 | ▲ +3.02% | ▼ −1.43% | $144.74 (+7.79%) |
Jul 6, 2026 12w ago | ANALYST-UPGRADE | $129.61 $130.21 | ▲ +0.46% | ▲ +1.03% | $144.74 (+11.67%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access